Frederick Larcombe

Frederick Larcombe

Director of Finance/CFO at
Heartland Bridge Capital, Inc.
69 year
Health Technology
Commercial Services
Finance

Profile

Mr. Fred Larcombe, CPA, is a Principal at Crimson Partners, Chief Financial Officer at iBIO, Chief Financial Officer, Secretary & Director at Heartland Bridge Capital, Inc., Chief Financial Officer at The Riderwood Group, Inc., and Chief Financial Officer at Heartland Bridge Capital, Inc. (Private Equity).
Mr. Larcombe has served as Chief Financial Officer for: Xenomics, a developer of DNA diagnostic tests; FermaVir Pharmaceuticals, a pharmaceutical development company; MicroDose Technologies, a drug delivery device company; and Genesis Direct, an internet retailer.
He started his professional career with PriceWaterhouseCoopers (PwC).
Mr. Larcombe received his BS in Accounting from Seton Hall University, and is a graduate of the Management Development Program at Harvard Business School.

Frederick Larcombe active positions

CompaniesPositionStart
Director of Finance/CFO 2011-07-27
Rittenhouse Food Corp.
Director of Finance/CFO 2014-12-31

Former positions of Frederick Larcombe

CompaniesPositionEnd
TOWERSTREAM CORPORATION Director of Finance/CFO 2017-05-14
Director of Finance/CFO 2015-12-31
Corporate Officer/Principal 2012-12-31
TRIR WELL Director of Finance/CFO 2012-10-24
IBIO, INC. Director of Finance/CFO 2011-05-02
See the detail of Frederick Larcombe's experience

Training of Frederick Larcombe

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

28

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies15

Retail Trade

Commercial Services

Health Technology

Consumer Services

Health Technology

Communications

Health Technology

Finance

Health Technology

Microdose Therapeutics

Electronic Technology

Rittenhouse Food Corp.

Finance

Your CFO Solution

Commercial Services

  1. Stock Market
  2. Insiders
  3. Frederick Larcombe